Feature Channels: AIDS and HIV

Filters close

Not for public release

This news release is embargoed until 12-Apr-2023 2:40 PM EDT Released to reporters: 12-Apr-2023 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Apr-2023 2:40 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Center for AIDS Research Receives $15 Million Renewal Grant From NIH
Released: 3-Apr-2023 2:00 PM EDT
Center for AIDS Research Receives $15 Million Renewal Grant From NIH
University of California San Diego

The National Institute of Allergy and Infectious Diseases has awarded a five-year, $15.45 million grant to the San Diego Center for AIDS Research at UC San Diego, renewing support that extends back to an original establishing grant in 1994 at the height of the AIDS epidemic.

Released: 3-Apr-2023 1:20 PM EDT
Late HIV diagnosis still an issue in Aotearoa
University of Otago

Forty per cent of people diagnosed with HIV in Aotearoa between 2011 and 2020 were diagnosed late, a University of Otago study shows.

Released: 28-Mar-2023 2:20 PM EDT
From the doctor's office to the operating room: Keep up with the latest in healthcare here
Newswise

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

Newswise: Researchers Identify a Plant-based Compound that Inhibits Reactivation of the HIV Viral Reservoir, Giving the Immune System a Break
Released: 28-Mar-2023 12:05 PM EDT
Researchers Identify a Plant-based Compound that Inhibits Reactivation of the HIV Viral Reservoir, Giving the Immune System a Break
Wistar Institute

Wistar Institute researchers identified hopeaphenol, a natural plant-based compound, as possessing antiviral properties that are effective against HIV.

   
Released: 28-Mar-2023 5:05 AM EDT
HIV and hepatitis C virus monitoring needs to increase to achieve global elimination goals
University of Bristol

Countries must intensify efforts to track HIV and hepatitis C virus (HCV) incidence among people who inject drugs, and to prioritise this group in prevention and elimination work, according to new University of Bristol-led research, published online in The Lancet Gastroenterology & Hepatology.

Newswise: Finger-prick test developed for ‘trich’ a common, undiagnosed STI
Released: 27-Mar-2023 11:05 AM EDT
Finger-prick test developed for ‘trich’ a common, undiagnosed STI
Washington State University

A quick, affordable diagnostic test developed by a Washington State University researcher may help curb one of the most prevalent but least discussed sexually transmitted infections.

Newswise: New Study: HIV Genomes That Hide in White Blood Cells Offer New Target to Eliminate Infections
23-Mar-2023 9:00 AM EDT
New Study: HIV Genomes That Hide in White Blood Cells Offer New Target to Eliminate Infections
Johns Hopkins Medicine

To develop treatments that may one day entirely rid the body of HIV infection, scientists have long sought to identify all of the places that the virus can hide its genetic code. Now, in a study using blood samples from men and women with HIV on long-term suppressive therapy, a team led by Johns Hopkins Medicine scientists reports new evidence that one such stable reservoir of HIV genomes can be found in circulating white blood cells called monocytes.

Newswise: A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy
Released: 24-Mar-2023 12:05 AM EDT
A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy
University of California, Los Angeles (UCLA), Health Sciences

MitoQ, a mitochondrial antioxidant that is available to the public as a diet supplement, was found in a mouse study to reverse the detrimental effects that HIV and antiretroviral therapy (ART) have on mitochondria in the brain, heart, aorta, lungs, kidney and liver.

Released: 20-Mar-2023 3:45 PM EDT
Stigma-coping intervention empowers people with HIV and drug use to engage in health, substance use care
Boston University School of Medicine

A new study from Boston University Chobanian & Avedisian School of Medicine has found that a brief stigma intervention that specifically targets people with HIV who inject drugs was effective in increasing engagement in substance use care as well as improving their ART adherence.

Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Newswise: USU’s Infectious Disease Clinical Research Program Hosts First Science Symposium
Released: 8-Mar-2023 2:15 PM EST
USU’s Infectious Disease Clinical Research Program Hosts First Science Symposium
Uniformed Services University of the Health Sciences (USU)

Infectious diseases like COVID, HIV, and battlefield wound infections cause illness and disruptions that threaten health and military readiness across the nation. To help foster collaboration in the field and share best practices, the Uniformed Service University’s (USU) Infectious Disease Clinical Research Program (IDCRP) is hosting its first annual Science Symposium March 6-10.

   
Released: 23-Feb-2023 8:05 AM EST
Case Western Reserve University completes exclusive license agreement with Atlanta-based RORA Biologics Inc. for cancer and HIV therapy technologies
Case Western Reserve University

Case Western Reserve University (CWRU) has completed an exclusive license agreement with Atlanta-based RORA Biologics Inc. (RORA-Bio) for intellectual property to develop new therapies to treat HIV and certain kinds of cancer.

   
Released: 21-Feb-2023 2:05 PM EST
A New Catalyst For Recycling Plastic, New Antioxidants Found In Meat, And Other Chemical Research News
Newswise

Below are some of the latest articles that have been added to the Chemistry news channel on Newswise.

Released: 20-Feb-2023 10:05 PM EST
Doxycycline does not prevent STIs among cisgender women
Hennepin Healthcare Research Institute

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women.

Released: 20-Feb-2023 10:05 PM EST
No safety concerns seen with use of dapivirine vaginal ring during third trimester of pregnancy, according to interim results of DELIVER study
Microbicide Trials Network, University of Pittsburgh

A vaginal ring containing the antiretroviral drug dapivirine posed no safety concerns when used in the third trimester of pregnancy, according to results to date from the first study of the dapivirine ring during pregnancy and one of only a few studies of an HIV prevention product in pregnant cisgender women.

Newswise: HIV Treatment and Prevention in Zambian Prisons May be Model for Prisons Worldwide
Released: 15-Feb-2023 1:15 PM EST
HIV Treatment and Prevention in Zambian Prisons May be Model for Prisons Worldwide
Institute of Human Virology at the University of Maryland School of Medicine

A recent study performed in Zambia by University of Maryland School of Medicine’s (UMSOM) Institute of Human Virology researchers found that high uptake of HIV preventative medicine, known as pre-exposure prophylaxis (PrEP), is possible in prison populations with adequate resources and support from the criminal justice health system.

Newswise: Texas Biomed HIV vaccine candidate aims to block virus before it takes root
Released: 15-Feb-2023 10:35 AM EST
Texas Biomed HIV vaccine candidate aims to block virus before it takes root
Texas Biomedical Research Institute

The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.

Newswise: CDC-UNC Collaboration Yields Potential Long-term HIV Protection
Released: 9-Feb-2023 8:45 AM EST
CDC-UNC Collaboration Yields Potential Long-term HIV Protection
University of North Carolina Health Care System

Since 2017, the lab of Rahima Benhabbour, PhD, MSc, associate professor in the UNC/NCSU Joint Department of Biomedical Engineering, has been working with a research team at the Centers for Disease Control and Prevention (CDC) and others at UNC to develop an injectable implant that can release HIV pre-exposure prophylaxis (PrEP) medications into the body for a long period of time. Their latest research, published in Nature Communications, shows that the team’s latest formulation can provide up to six months of full protection.

Released: 7-Feb-2023 12:05 PM EST
Resilience to HIV-Related Stigma May Be Key to Ending the AIDS Epidemic
Rutgers University-New Brunswick

Failing to address the psychological trauma experienced by many older people living with HIV/AIDS will make it difficult, if not impossible, to end the epidemic, according to a Rutgers study.

Newswise: Uncovering Sexual Health Topics for Parents to Address with Their Adolescent-aged GBQ Male Children
Released: 7-Feb-2023 11:00 AM EST
Uncovering Sexual Health Topics for Parents to Address with Their Adolescent-aged GBQ Male Children
University of Pennsylvania School of Nursing

Comprehensive and inclusive sexual health education reduces young gay, bisexual, and queer (GBQ) men's vulnerability to poor sexual health outcomes like HIV and STIs into adulthood, data shows. However, conservative ideologies continue to dominate policies on school-based sex education and view topics like same-sex attractions as controversial.

Released: 2-Feb-2023 3:45 PM EST
FSU Nursing awarded $72.7M NIH grant to lead adolescent HIV clinical trial network
Florida State University

Florida State University has been awarded a $72.7 million grant from the National Institutes of Health (NIH) to redesign and improve HIV prevention and care interventions in adolescents and young adults in the United States. Under the grant, which will be dispersed over the course of seven years, FSU will serve as the Scientific Leadership Center (SLC) for the Adolescent Medicine Trials Network for HIV Interventions.

Released: 31-Jan-2023 5:05 PM EST
The latest research news on surgery and transplants
Newswise

Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.

Newswise: Scientists Document Two Separate Reservoirs of Latent HIV in Patients
Released: 31-Jan-2023 12:05 PM EST
Scientists Document Two Separate Reservoirs of Latent HIV in Patients
University of North Carolina School of Medicine

UNC-Chapel Hill scientists and colleagues provide indirect evidence for the existence of a distinct latent reservoir of CD4+ T cells in the central nervous system, by analyzing rebound virus in the cerebral spinal fluid during the period when people had just stopped taking ART.

Released: 31-Jan-2023 9:30 AM EST
Study Suggests Side-Effects and Costs Are Biggest Concerns for Users of HIV Pre-Exposure Prophylaxis
Johns Hopkins Bloomberg School of Public Health

A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting injections over pills, but rank side effects and costs as the most important issues for them in considering whether to take PrEP.

Released: 30-Jan-2023 5:20 PM EST
SLU Researcher Receives $1.76 Million NIH Grant to Create STAR, an HIV-Focused Experiential Research and Capacity Building Program for Students and Young Researchers
Saint Louis University Medical Center

Using a crowdsourcing framework utilized over the past five years, Juliet Iwelunmor, Ph.D., professor of global health and behavioral science and health education at Saint Louis University’s College for Public Health and Social Justice, is taking what she learned from empowering youth in Nigeria to identify young people in the United States who aim to become the next generation of HIV researchers, leaders and innovators in the field.

Released: 30-Jan-2023 11:05 AM EST
Moffitt Cancer Center Joins Weill Cornell Medicine and University of North Carolina to Improve HIV-Related Cancer Care Abroad
Moffitt Cancer Center

Moffitt Cancer Center, Weill Cornell Medicine and the University of North Carolina School of Medicine have received a $3.5 million, five-year grant from the National Cancer Institute (NCI) to improve screening and preventative treatment of cervical cancer for women living with HIV in low-resource countries.

Released: 26-Jan-2023 12:55 PM EST
UAlbany Researchers Receive New Funding for Suicide Prevention Programming
University at Albany, State University of New York

Researchers in University at Albany’s Center for Behavioral Health Promotion and Applied Research in the School of Education have received funding to undertake a new project aimed at reducing risk for suicide and substance use among students experiencing health disparities. The work aims to hone strategies that could be implemented widely across college campuses.

Released: 20-Jan-2023 10:05 AM EST
Social support can increase syphilis testing in Black sexual minority men
Wolters Kluwer Health: Lippincott

Black sexual minority men who give and receive support within their social networks are more likely to be tested for syphilis. Therefore, nurses should prepare patients to inform and encourage their social networks to seek testing for syphilis, HIV, and other sexually transmitted infections (STIs). These conclusions come from a paper in the January issue of The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
Released: 19-Jan-2023 2:35 PM EST
Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
Wistar Institute

amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years.

Newswise: Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production
Released: 18-Jan-2023 7:45 PM EST
Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production
University of California, Los Angeles (UCLA), Health Sciences

New UCLA-led research suggests that antiretroviral drugs called TAF and TDF directly reduce energy production by mitochondria, structures inside cells that generate the power that cells use to function. Both drugs led to reduced cellular oxygen consumption rates, a measure of the ability of the mitochondria to produce energy, compared with controls.

Released: 18-Jan-2023 1:00 PM EST
People with HIV Experience Higher Rates of Inflammation and Immune Activity During Pregnancy
Rutgers University-New Brunswick

People with HIV have a higher chance of having chronic systemic inflammation during pregnancy, according to a Rutgers study.

Released: 18-Jan-2023 10:00 AM EST
Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review
HIV Vaccine Trials Network

A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board. The investigational vaccine was generally safe and well tolerated; however, it was not effective at preventing the acquisition of HIV-1. The results of the uniquely designed and implemented Mosaico study underscore the challenges that have faced the global scientific community in the 40-year search for an HIV vaccine, and may provide important data in the ongoing fight against HIV.

Released: 17-Jan-2023 11:30 AM EST
Researchers Identify How HIV/Hepatitis Drug Harms the Kidneys
American Physiological Society (APS)

A first-of-its-kind study identifies mechanisms that explain how a drug commonly used to treat HIV and hepatitis causes kidney disease and kidney injury. The study is published ahead of print in Function.

Newswise: Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency
Released: 10-Jan-2023 5:50 PM EST
Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency
University of Ottawa

Understanding HIV latency at the molecular level is crucial for efforts to eliminate the viral scourge that causes AIDS.

Released: 12-Dec-2022 1:30 PM EST
Medicaid expansion plus PrEP and antivirals could lower HIV transmission in Houston, model projects
Wolters Kluwer Health: Lippincott

Enacting Medicaid expansion in Texas and increasing the use of preventive and antiviral medications could result in a decline of new HIV infections among young Black gay, bisexual, and other men who have sex with men (MSM) in Houston, reports a study in the January issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Phase 1 Trial of the First-In Human HIV Vaccine Shows Promising Results
Released: 8-Dec-2022 10:05 AM EST
Phase 1 Trial of the First-In Human HIV Vaccine Shows Promising Results
George Washington University

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science.

Released: 1-Dec-2022 11:55 AM EST
FSU experts weigh in on potential FDA change to blood donation policy
Florida State University

Several national media outlets are reporting that the FDA is considering a new strategy for screening gay and bisexual men to help combat the national blood shortage. Florida State University’s nationally recognized experts are available to provide context to reporters who are working on this story as it develops.

Newswise: Lung Cancer Screening Has the Potential to Reduce HIV Deaths
Released: 1-Dec-2022 8:00 AM EST
Lung Cancer Screening Has the Potential to Reduce HIV Deaths
American Thoracic Society (ATS)

This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on the health care community to increase lung cancer screening for people with HIV who are current or former heavy smokers and may be at high risk for developing the disease. As HIV- infected individuals have high smoking rates, smoking cessation should also be encouraged.

Newswise: HIV Infection Leaves a ‘Memory’ in Cells
Released: 22-Nov-2022 11:25 AM EST
HIV Infection Leaves a ‘Memory’ in Cells
George Washington University

Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of their lives.

Released: 17-Nov-2022 9:35 AM EST
Mount Sinai Geriatricians to Develop Model Health Care Program for Older Adults With HIV
Mount Sinai Health System

A team of geriatricians at Mount Sinai’s Brookdale Department of Geriatrics and Palliative Medicine has been awarded $1.25 million from the Health Resources and Services Administration and the Keith Haring Foundation to expand Mount Sinai’s interdisciplinary model of care for older patients living with HIV.

Released: 14-Nov-2022 1:05 PM EST
Study Identifies How Stealthy HIV Evades Drugs and Immunity
Duke Health

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

Released: 14-Nov-2022 10:05 AM EST
Preventing the next pandemic: Leaders of Pacific Rim Universities meet in Bangkok, Thailand
Newswise

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

       
Released: 10-Nov-2022 1:30 PM EST
Chronic jet lag discovered in people living with HIV
Northumbria University

People living with HIV have a significantly delayed internal body clock, consistent with the symptoms of jet lag, according to new findings reported by researchers from universities in South Africa and the UK.

Newswise: UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
Released: 10-Nov-2022 10:35 AM EST
UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
University of Texas Health Science Center at Houston

Research shows that incidences of Kaposi’s sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.

Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Newswise: NCI Grants Awarded to IHV to Prevent Cancer and Improve Screening in Sub-Saharan Africa
Released: 31-Oct-2022 4:10 PM EDT
NCI Grants Awarded to IHV to Prevent Cancer and Improve Screening in Sub-Saharan Africa
University of Maryland School of Medicine

Institute of Human Virology researchers at the University of Maryland School of Medicine have received two five-year awards from the National Institutes of Health’s National Cancer Institute for a total of $7.5 million. One award aims to reduce the incidence of lung cancer and other cancers associated with using tobacco in Botswana. The other is focusing on improving screening and treatment of anal precancer in Nigeria. Both grants will make use of existing HIV treatment and prevention infrastructure in low- and middle-income countries to reach people living with HIV who are most at risk for these particular types of cancers.



close
1.48338